瑞马迎春贺新岁 We welcome the Year of the Horse!
Our Business Analytics Service Category comprises all service offerings previously listed under the Core Capabilities of Due Diligence & Business Strategy, Market Expertise, and Quantitative Modeling. Whether you’re a developer, in the process of developing a tools & tech offering, are a company seeking funding, or are an investor considering investing in the CGT space, our experts are available to provide due diligence, strategy support, market research, and quantitative modeling services.
We are frequently called upon by investors to perform due diligence on companies in the CGT space. Alternatively, for companies seeking investment, our mock diligence service can help ensure you are prepared for questions investors may raise.
Our knowledge of the biopharma landscape can help you identify investment targets that are well-aligned with your portfolio objectives.
Are you an experienced investor who is new to the complex world of CGT? Or an existing pharma or biotech company that has recently acquired a cell and gene asset? We provide customized CGT teach-ins.
Our unique combination of deep technical expertise and investor relations experience allows us to provide a candid assessment of your program and strategic planning for an optimal 'pitch.'
Knowing the right questions to ask and the right respondents to contact is the secret to getting actionable survey results that speak specifically to your product and the market. Our experts have more combined years of experience in the CGT field than any other consulting practice; in fact, many of us have been in the space since the very beginning. There is no substitute for direct experience and meaningful connections when building a survey or a set of respondents.
Our unmatched experience in this industry means that we have a deeper understanding of existing offerings and competitive environments than your company can get anywhere else. An informed assessment of market needs gets far beyond the buzzwords and the latest trends, aligning unmet needs with opportunities for future therapies and the tools & tech necessary to create those therapies. Having watched this industry for decades, we've also seen a range of typical pitfalls and oversights and are equipped to help you avoid those.
We both are your target customers and work with your target customers every day. Living amidst the technical details of this space has provided us with an understanding of what your customers are looking for, what their pain points are, and what messaging will resonate with them. We know how to strategize effectively in biopharma, no matter what your stage of market readiness may be.
Predict facility size requirements, instrumentation needs, and FTE by department over time under the full range of reasonable input assumptions to enable robust scenario planning even in environments of great uncertainty. Delivered via Pegasi, DHCG's proprietary data-modeling application, which is designed to model uncertainty.
Evaluate the range of likely product COGs over time and evaluate key levers for cost reduction based on the impact of various input assumption on overall product COGs. Delivered via Pegasi, DHCG's proprietary data-modeling application, which is designed to model uncertainty.
Determine current and project future market size for your product or services based on inputs such as patient/user/customer type, indication prevalence, and assumed market penetration. Delivered via Pegasi, DHCG's proprietary data-modeling application, which is designed to model uncertainty.
Model profitability scenarios based on COGs, OpEx, CapEx, and market size inputs. Delivered via Pegasi, DHCG's proprietary data-modeling application, which is designed to model uncertainty.
.png)
